A dual-action niclosamide-based prodrug that targets cancer stem cells and inhibits TNBC metastasis
Chemotherapy typically destroys the tumor mass but rarely eradicates the cancer stem cells (CSCs) that can drive metastatic recurrence. A key current challenge is finding ways to eradicate CSCs and suppress their characteristics. Here, we report a prodrug, Nic-A, created by combining a carbonic anhy...
Saved in:
Main Authors: | Ji Hyeon Kim, Soeun Park, Eunsun Jung, Jin Woo Shin, Yoon-Jae Kim, Ji Young Kim, Jonathan L. Sessler, Jae Hong Seo, Jong Seung Kim |
---|---|
格式: | Artigo |
語言: | 英语 |
出版: |
2023
|
在線閱讀: | https://doi.org/10.1073/pnas.2304081120 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|
相似書籍
-
Metformin overcomes resistance to cisplatin in triple-negative breast cancer (TNBC) cells by targeting RAD51
由: Lee, Jung Ok, et al.
出版: (2019) -
Metformin overcomes resistance to cisplatin in triple-negative breast cancer (TNBC) cells by targeting RAD51
由: Jung Ok Lee, et al.
出版: (2019) -
Combined effects of niclosamide and temozolomide against human glioblastoma tumorspheres
由: Oh, Hyeong-Cheol, et al.
出版: (2020) -
Comparisons of Oncologic Outcomes between Triple-Negative Breast Cancer (TNBC) and Non-TNBC among Patients Treated with Breast-Conserving Therapy
由: Kim, Sanghwa, et al.
出版: (2016) -
Bioanalysis of niclosamide in plasma using liquid chromatography-tandem mass and application to pharmacokinetics in rats and dogs
由: Choi, Hae-In, et al.
出版: (2021)